1-3 of 3
David C. Dalgarno
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Discovery of Potent and Selective Next-Generation Pan-BCR-ABL Inhibitors for the Treatment of CML and Ph+ ALL

Yun Zhang, Sara Nadworny, Shengwu Liu, Sen Zhang, Emily Ye, Narayana Narasimhan, David C Dalgarno, Justin Pritchard, Wei-Sheng Huang, William C Shakespeare, Victor M Rivera
Journal: Blood
Blood (2023) 142 (Supplement 1): 1428.
https://doi.org/10.1182/blood-2023-172982
Published: 2023
Journal Articles

In Vitro and In Vivo Activity of the Src/Abl Kinase Inhibitor AP23464 and Analogs Against Activation Loop Mutants of KIT.

Amie S. Corbin, Shadmehr Demehri, Ian J. Griswold, Chester A. Metcalf, III, William C. Shakespeare, Joseph Snodgrass, Scott Wardwell, David C. Dalgarno, John Iuliucci, Tomi K. Sawyer, Brian J. Druker, Michael W. Deininger
Journal: Blood
Blood (2004) 104 (11): 793.
https://doi.org/10.1182/blood.V104.11.793.793
Published: 2004
Journal Articles

Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model

Carolina Berger, C. Anthony Blau, Meei-Li Huang, John D. Iuliucci, David C. Dalgarno, Joëlle Gaschet, Shelly Heimfeld, Tim Clackson, Stanley R. Riddell
Journal: Blood
Blood (2004) 103 (4): 1261–1269.
https://doi.org/10.1182/blood-2003-08-2908
Published: 2004